Literature DB >> 9626123

Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance.

D Chin1, P W Speiser, J Imperato-McGinley, N Dixit, N Uli, R David, S E Oberfield.   

Abstract

We sought to determine the concordance of the phenotype and genotype in a kindred with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The variation in phenotypic expression within this family underscores the difficulty of establishing the diagnosis in the absence of newborn screening, even with a heightened index of suspicion. Steroidogenic profiles were obtained for the three affected siblings. The available clinical history of the two affected aunts was retrieved. Genotyping was performed on several members of the kindred. Detailed sequencing of the entire CYP21 gene of two clinically dissimilar subjects in this family was undertaken to explore the possibility of other mutations or polymorphisms. PCR with ligase detection reaction analysis of CYP21 revealed that the affected family members III-2, III-3, III-4, II-3, and II-4, all were compound heterozygotes carrying the intron 2 point mutation known to interfere with splicing (nucleotide 656 A to G) and the exon 4 point mutation causing a nonconservative substitution of asparagine for isoleucine at codon 172 (I172N). Detailed sequencing of the gene was performed for the two most phenotypically dissimilar subjects. A single silent polymorphism was found in the third nucleotide for codon 248 in patient II-4, but not in patient III-4, and no additional mutations were found. Classic congenital adrenal hyperplasia remains a difficult diagnosis to make in the absence of newborn screening because of the variability of phenotypic expression. Likewise, the variable degree of genital ambiguity in affected females in this family serves to question universal advocacy of prenatal steroid treatment in pregnancies at risk for congenital adrenal hyperplasia. Extensive molecular exploration did not provide an explanation of the phenotypic heterogeneity and supports the possibility of influences other than the CYP21 gene for the observed divergence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626123     DOI: 10.1210/jcem.83.6.4887

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.

Authors:  Firdevs Baş; Hülya Kayserili; Feyza Darendeliler; Oya Uyguner; Hülya Günöz; Memnune Yüksel Apak; Fatmahan Atalar; Rüveyde Bundak; Robert C Wilson; Maria I New; Bernd Wollnik; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-02

2.  Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia.

Authors:  Ingeborg Brønstad; Lars Breivik; Paal Methlie; Anette S B Wolff; Eirik Bratland; Ingrid Nermoen; Kristian Løvås; Eystein S Husebye
Journal:  Endocr Connect       Date:  2014-04-15       Impact factor: 3.335

3.  Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.

Authors:  Aida Aljabri; Fatimah Alnaim; Yasin Alsaleh
Journal:  BMJ Case Rep       Date:  2020-09-29

Review 4.  Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Mahsa Kolahdouz; Zahra Mohammadi; Parisa Kolahdouz; Masoud Tajamolian; Hossein Khanahmad
Journal:  Adv Biomed Res       Date:  2015-08-31

5.  Assessment of Facial Morphologic Features in Patients With Congenital Adrenal Hyperplasia Using Deep Learning.

Authors:  Wael AbdAlmageed; Hengameh Mirzaalian; Xiao Guo; Linda M Randolph; Veeraya K Tanawattanacharoen; Mitchell E Geffner; Heather M Ross; Mimi S Kim
Journal:  JAMA Netw Open       Date:  2020-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.